OSL •
Healthcare •
Biotechnology •
Quote as of 09/03/2026 13:27
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOSL
Market Capitalization72.78 mln
Float12.29 mln
Earnings Date08/27/2026
Relative Strength
8
/ 100
Severely lagging
Debt / Equity
0.36
Low leverage
ROE
-21.36
Deeply negative
DPS
0.00
Payout Ratio
0%
No payout
ROA
-7.41
Negative
Business Description
Founded in 2011 and based in Ørsta, Norway, Arctic Bioscience AS develops medicines and health supplements derived from marine sources, with operations spanning Europe, the United States, and Asia Pacific. Its lead product, HRO350, is an oral treatment for mild-to-moderate psoriasis currently in Phase IIb clinical trials. The company also sells consumer health supplements through its ROMEGA brand.
